HNC364 - Phase I Clinical Trial • Frontage Laboratories

HNC364 – Phase I Clinical Trial

Frontage Clinical Services prioritizes the safety and well-being of our study participants, our employees, and visitors to our clinic. As such, we have incorporated additional policies and procedures, as recommended by the CDC.

Participate in a Phase I Clinical Trial

Compensation between $12,000 to $15,650 for your time and participation.

This is a Phase 1 research study to compare a investigational injectable medication (HNC364) with an approved oral medication called AZILECT. The goal is to see how the new drug works in the body, and to check its safety and how well it is tolerated.

Eligibility Criteria

Be a Healthy Adult
Be 18 to 55 years old
Have a BMI between 18 to 32.0 kg/m²
Be a Non-Smokers, Non-Vapers and not used other Tabacco Products
Have a Good Venous Access

Study Requirements:

If you are chosen for the investigational Injection Group (HNC364):

You will receive 4 study drug injections in the shoulder, once every 4 weeks.
Total study length: about 5–6 months
Clinic stay: 4 overnight stays (one per dose)
Additional 4 outpatient visits between doses
Requirement: 4 separate one night stay in the clinic and 4 follow-up visits in between doses
Compensation: up to $12,000 upon completion

If you are chosen for the Tablet Group (AZILECT):

You will take a pill once daily for 25 days
Total study length: about 2 months
Clinic stay: about 25 consecutive overnights
1 follow-up visit after discharge
Requirement: 26 overnight stays (27days) and one follow-up visit
Compensation: up to $15,650 upon completion

Application for Clinical Research Study

Research StudyHNC364 – Phase I Clinical Trial

*First Name

*Last Name

*Date of Birth

*Phone Number:

Email address:

Your information will be used solely for research recruitment purposes by our research team and will not be shared externally. All submissions are stored securely in accordance with HIPAA and Good Clinical Practice (GCP) standards.

Please fill out all required fields.

About our Clinical Research Facility

The Frontage Clinical Research Center in New Jersey is a modern, comfortable facility located within 20 miles of New York City in Secaucus, NJ. It is easily accessible by car, train or bus. There are 160 beds that are arranged in different areas of the facility, which can be further divided for additional privacy. The frontage staff is highly qualified, experienced and friendly and treats all volunteers with respect and compassion.

Printable Version of this Clinical Research Flyer